3-((E)-2-Dimethylamino-vinyl)-isonicotinonitrile, 95.0%, 1g

2-((2-Methylbenzyl)oxy)benzoic acid, 95.0%, 100mg

PYRIDINE-2-SULFONYL FLUORIDE, 95.0%, 5g

(2E)-1-(3-methoxyphenyl)-3-(2-methylphenyl)prop-2-en-1-one, 95.0%, 2g

Thalidomide-O-amido-PEG-C2-NH2 (hydrochloride), 25mg

2-methylbutan-1-ol, 25g

4-Ethyl-3-hydroxybenzoic acid, 98%, 1g

1-(4-Bromo-2-fluorophenyl)cyclopropanecarboxylic acid, 95.0%, 250mg

Phase separating paper MN 616 WA, 100 Piece(s)

Ethyl 2-amino-4-bromo-3-methylbenzoate, 98%, 500mg

Ethyl 4-Nitrophenylacetate>98.0%(GC)25g

3,5-Bis-trifluoromethyl-benzoic acid ethyl ester, 95.0%, 1g

6-Bromo-2-methyloxazolo[5,4-b]pyridine, 95.0%, 10g